AstraZeneca
(NASDAQ:AZN)
$68.465
0.105[0.15%]
Last update: 10:11AM Get Real Time Here
Q1 2024 Earnings in 6 days from now on Thu Apr 25th, before the market open
Conference call scheduled in 6 days at 6:45 AM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

AstraZeneca Stock (NASDAQ:AZN), Quotes and News Summary

AstraZeneca Stock (NASDAQ: AZN) stock price, news, charts, stock research, profile.

Open$68.140
Close-
Volume / Avg.650.221K / 6.296M
Day Range68.130 - 68.550
52 Wk Range60.470 - 76.560
Market Cap$212.272B
P/E Ratio35.885
Dividend Yield2.120%
ExchangeNASDAQ
RSI
58
Short Interest-
Days to Cover1.74

Recent News

Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
Amgen's Tezspire shows promising COPD trial results and potential market expansion beyond asthma. Comparison with Dupixent reveals significant benefits for eosinophil counts ≥150 cells/μL and ≥300 cells/μL.
Vandana Singh
AstraZeneca's Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows
AstraZeneca's updated data from TOPAZ-1 Phase 3 trial of Imfinzi (durvalumab) in advanced biliary tract cancer patients. Unveiling long-term survival benefits and significant overall survival improvement.
Vandana Singh
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee found no conclusive evidence linking GLP-1 receptor agonists to suicidal or self-injurious thoughts. Following thorough reviews and data analyses, no changes to product information were deemed necessary.
Vandana Singh
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
1
Feb
0
0
0
0
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Astrazeneca plc
Sector
Health Care
Industry
Pharmaceuticals
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
AZN
NVO

FAQ

Q

How do I buy AstraZeneca (AZN) stock?

A

You can purchase shares of AstraZeneca (NASDAQ: AZN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are AstraZeneca's (AZN) competitors?

A

Other companies in AstraZeneca’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for AstraZeneca (AZN) stock?

A

The latest price target for AstraZeneca (NASDAQ: AZN) was reported by Deutsche Bank on Tuesday, April 16, 2024. The analyst firm set a price target for 0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for AstraZeneca (AZN)?

A

The stock price for AstraZeneca (NASDAQ: AZN) is $68.46 last updated Today at April 19, 2024 at 10:11 AM EDT.

Q

Does AstraZeneca (AZN) pay a dividend?

A

A quarterly cash dividend of $1.97 per share of Class A Common Stock. The quarterly cash dividend was payable on March 25, 2024 to stockholders of record on February 22, 2024.

Q

When is AstraZeneca (NASDAQ:AZN) reporting earnings?

A

AstraZeneca’s Q1 earnings are confirmed for Thursday, April 25, 2024.

Q

Is AstraZeneca (AZN) going to split?

A

There is no upcoming split for AstraZeneca.

Q

What sector and industry does AstraZeneca (AZN) operate in?

A

AstraZeneca is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch